Trial Profile
A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2018
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Nedaplatin (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 13 Aug 2018 Status changed from active, no longer recruiting to completed.
- 15 Jan 2014 Planned End Date changed from 1 Mar 2017 to 1 Dec 2016 as reported by University Hospital Medical Information Network - Japan.
- 17 Jan 2012 Planned end date 1 Mar 2017 added as reported by University Hospital Medical Information Network - Japan.